Axogen Overview

  • Year Founded
  • 1977

Year Founded

  • Status
  • Public

  • Employees
  • 622

Employees

  • Stock Symbol
  • AXGN

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $55.40
  • (As of Thursday Closing)

Axogen General Information

Description

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Contact Information

Website
www.axogeninc.com
Formerly Known As
Lectec
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 13631 Progress Boulevard
  • Suite 400
  • Alachua, FL 32615
  • United States
+1 (386)
Primary Industry
Biotechnology
Stock Exchange
NAS
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 13631 Progress Boulevard
  • Suite 400
  • Alachua, FL 32615
  • United States
+1 (386)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axogen Stock Performance

As of 12-Nov-2026, Axogen’s stock price is $55.40. Its current market cap is $3.31B with 59.7M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$55.40 $58.63 $23.00 - $59.72 $3.31B 59.7M 1.54M -$0.63

Axogen Financials Summary

As of 30-Sep-2026, Axogen has a trailing 12-month revenue of $267M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,368,164 1,541,706 769,588 328,801
Revenue 266,926 225,208 187,338 159,012
EBITDA (20,121) 507 6,079 (13,328)
Net Income (31,922) (15,703) (9,964) (21,716)
Total Assets 550,339 221,687 203,728 196,827
Total Debt 19,469 67,629 68,686 69,292
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Axogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axogen‘s full profile, request access.

Request a free trial

Axogen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regenerati
Biotechnology
Alachua, FL
622 As of 2025

Marietta, GA
 

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axogen Competitors (26)

One of Axogen’s 26 competitors is Mimedx Group, a Corporation company based in Marietta, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mimedx Group Corporation Marietta, GA
TELA Bio Formerly VC-backed Malvern, PA
Organogenesis Holdings Pending Transaction (M&A) Canton, MA
Moraga Biotechnology Corporation Corporation Los Angeles, CA
Gemstone Biotherapeutics Venture Capital-Backed Baltimore, MD
You’re viewing 5 of 26 competitors. Get the full list »

Axogen Patents

  • 504

    Total Documents Applications and Grants

  • Total Patents Families

  • 261

    Granted

  • 101

    Pending

  • Expiring in next 12 mo

Axogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260192013-A1 Adhesive tissue covering Pending 06-Jan-2025
WO-2026148250-A1 Adhesive tissue covering Pending 06-Jan-2025
US-20260085979-A1 Medical devices and related methods for detecting a change in temperature Pending 26-Sep-2024
WO-2026072408-A1 Medical devices and related methods for detecting a change in temperature Pending 26-Sep-2024
AU-2025220523-A1 Barbed devices for securing tissue Pending 09-Feb-2024 A61B17/06166
To view Axogen’s complete patent history, request access »

Axogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axogen Investments & Acquisitions (3)

Axogen’s most recent deal was a Merger/Acquisition with BioCircuit Technologies for . The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioCircuit Technologies 01-Oct-2026 Merger/Acquisition Surgical Devices
Trace Biosciences 30-Jul-2026 Later Stage VC Surgical Devices
Lectec 30-Sep-2011 Merger/Acquisition Drug Delivery
To view Axogen’s complete investments and acquisitions history, request access »

Axogen ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

31.1 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Axogen’s complete esg history, request access »

Axogen Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
BioCircuit Technologies Atlanta, GA 2016
Lectec Texarkana, TX 1977

Axogen FAQs

  • When was Axogen founded?

    Axogen was founded in 1977.

  • Where is Axogen headquartered?

    Axogen is headquartered in Alachua, FL.

  • What is the size of Axogen?

    Axogen has 622 total employees.

  • What industry is Axogen in?

    Axogen’s primary industry is Biotechnology.

  • Is Axogen a private or public company?

    Axogen is a Public company.

  • What is Axogen’s stock symbol?

    The ticker symbol for Axogen is AXGN.

  • What is the current stock price of Axogen?

    As of 12-Nov-2026 the stock price of Axogen is $55.40.

  • What is the current market cap of Axogen?

    The current market capitalization of Axogen is $3.31B.

  • What is Axogen’s current revenue?

    The trailing twelve month revenue for Axogen is $267M.

  • Who are Axogen’s competitors?

    Mimedx Group, TELA Bio, Organogenesis Holdings, Moraga Biotechnology Corporation, and Gemstone Biotherapeutics are some of the 26 competitors of Axogen.

  • What is Axogen’s annual earnings per share (EPS)?

    Axogen’s EPS for 12 months was -$0.63.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process